Related Experiment Videos
Flurbiprofen-aspirin interaction: a double-blind crossover study
Abstract:
Fifteen patients with seropositive rheumatoid arthritis were treated for 2-weeks periods with 150 mg flurbiprofen daily and with flubriprofen in the same dosage plus 3 g aspirin daily, the treatments being administered in random allocation. The results showed that there were no significant differences clinically between the two treatments. Serum levels of flurbiprofen were measured during both treatment periods in 4 patients. During the flurbiprofen and aspirin period there was a full in the serum levels of flurbiprofen was unchanged. No obvious reduction in clinical efficacy was apparent.
Insights
Adding aspirin to flurbiprofen did not significantly alter clinical efficacy in rheumatoid arthritis patients. Serum flurbiprofen levels showed a drop when combined with aspirin, but overall effectiveness remained comparable.
Area of Science:
- Rheumatology
- Pharmacology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) like flurbiprofen are used for RA symptom management.
Purpose of the Study:
- To investigate the clinical efficacy and serum levels of flurbiprofen when co-administered with aspirin in patients with seropositive rheumatoid arthritis.
Main Methods:
- A randomized, 2-week treatment period comparing flurbiprofen alone (150 mg/day) versus flurbiprofen plus aspirin (3 g/day).
- Clinical efficacy was assessed, and serum flurbiprofen levels were monitored in a subset of patients.
Main Results:
- No significant clinical differences were observed between the flurbiprofen-only and flurbiprofen-aspirin treatment groups.
- Serum levels of flurbiprofen decreased during the co-administration period with aspirin, although this did not appear to affect overall clinical efficacy.
Conclusions:
- Co-administration of aspirin with flurbiprofen does not appear to significantly impact the clinical efficacy for managing rheumatoid arthritis symptoms.
- Further investigation into the pharmacokinetic interactions and clinical implications of this combination is warranted.